Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug development experts say Sanofi's planned switch for Allegra should present few regulatory hurdles, but other products the firm identified as possible switch candidates - Penlac Nail Lacquier, BenzaClin Topical Gel and Nasacort nasal spray would - challenge even the most experienced switch hands.